Health And Medicine

Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors. Read More

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes. Read More

The implementation of state prescription drug monitoring programs was associated with the prevention of approximately one opioid-related overdose death every two hours on average nationwide, according to a new Vanderbilt-led study released this week in the journal "Health Affairs." Read More

Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery. Read More

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been selected to testify before members of Congress about the importance of cancer research, including early training programs for individuals interested in science. Read More

Provost and Vice Chancellor for Academic Affairs Susan R. Wente has appointed an 18-member committee of faculty and students to conduct the national search for the Barlow Family Director of the Vanderbilt Brain Institute chaired by Randolph Blake, Centennial Professor of Psychology, and Danny Winder, director for the Vanderbilt Center for Addiction Research. Read More

Researchers at Vanderbilt University Medical Center this month began recruiting volunteers to participate in a clinical trial aimed at decoding the human “immunome,” the genetic underpinnings of the immune system. Read More

Children who don’t get adequate rest are at risk for health problems ranging from diabetes to depression, according to the American Academy of Sleep Medicine, which this week issued age-specific sleep recommendations. Read More

Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA). Read More

A new report released this week raises questions about “gene drives,” a biological process that can profoundly and rapidly alter the characteristics of entire species. Read More

A new study finds that uninsured heart attack patients are more likely to be transferred. Read More

New findings identify isoketal-modified proteins as a previously unrecognized feature of pulmonary fibrosis and as a potential therapeutic target for this disease. Read More

Vanderbilt researchers have identified biomarkers that could be useful for evaluating and treating pregnancy-related heart failure. Read More

A genetic risk factor for Alzheimer’s disease in later life appears to benefit younger adults as they age. Read More

Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar by the Susan G. Komen organization. Read More

Katherine Gifford, Psy.D., is testing simple questions to see which ones yield the most reliable results as she develops a questionnaire for primary care providers to quickly identify patients at risk for cognitive decline. Read More

A research team at Vanderbilt University Medical Center (VUMC) will develop a crowdsourcing solution for generating a wide range of labeled data sets from electronic health records (EHRs). Read More

Sepsis, an exaggerated and overwhelming inflammatory response to infection, is a major worldwide killer of babies in the first four weeks of life (neonatal period). Read More

A team at Vanderbilt University Medical Center (VUMC) has developed and tested software that scans electronic health records in real time to monitor cancer patient survival (from time of diagnosis) according to which genes, if any, are found to carry mutations. Read More

Childhood stroke patients with hyperglycemia may be more at risk for disability, according to a Vanderbilt University Medical Center (VUMC) study that sought to determine if vital sign measurements and blood glucose levels could be associated with poor neurological outcomes. Read More